Cryo-Cell International Inc. (CCEL) vs The Joint Corp. (JYNT)
- Cryo-Cell International Inc. CCEL 4.42 +21.10%
- The Joint Corp. JYNT 7.03 +1.74%
Cryo-Cell International Inc. and The Joint Corp. are both Medical Care Facilities companies. The Joint Corp. is the larger, with a market value of $97.7M against $29.4M — 3.3× the size. Cryo-Cell International Inc. has negative trailing earnings, so its P/E is not meaningful; The Joint Corp. trades at 26.0×. The Joint Corp. grew revenue faster over the last twelve months: 9.00% against −1.96%. The Joint Corp. has the higher net margin (6.49% vs −6.25%) and the higher return on invested capital (0.00% vs 0.00%). Across the 18 metrics below, The Joint Corp. leads on 11 and Cryo-Cell International Inc. on 7.
Valuation
Profitability
| Metric | CCEL | JYNT | Medical Care Facilities median |
|---|---|---|---|
| Gross margin | 78.54% | 81.76% | 30.78% |
| Operating margin | 0.61% | 2.41% | 5.74% |
| Net margin | (6.25%) | 6.49% | 2.32% |
| Free cash flow margin | 14.94% | 7.22% | 5.46% |
| Return on equity | 12.46% | 19.41% | 8.76% |
| Return on assets | (3.10%) | 6.09% | 2.18% |
| Return on invested capital | 0.00% | 0.00% | 5.01% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack